| CAS NO: | 1202400-18-7 |
| 包装 | 价格(元) |
| 100mg | 电议 |
| 250mg | 电议 |
| 500mg | 电议 |
| 生物活性 | BMS-817399 is a potent, selective, and orally bioavailableCCR1antagonist. BMS-817399 exhibitsCCR1binding affinity and chemotaxis inhibition potencies of 1 and 6 nM (IC50), respectively. BMS-817399 can be used for the research of rheumatoid arthritis[1]. | |
| IC50& Target[1] |
| |
| 体外研究 (In Vitro) | In addition to MIP-1α (CCL3), BMS-817399 potently inhibits chemotaxis induced by other CCR1 ligands[1]. | |
| Clinical Trial | ||
| 分子量 | 454.00 | |
| Formula | C23H36ClN3O4 | |
| CAS 号 | 1202400-18-7 | |
| 运输条件 | Room temperature in continental US; may vary elsewhere. | |
| 储存方式 | Please store the product under the recommended conditions in the Certificate of Analysis. |
m.cnreagent.com